CCL22



CCL22

G1GG1P2PP2Y3YY3G4GG4A5AA5N6NN6M7MM7E8EE8D9DD9S10SS10V11VV11C12CC12C13CC13R14RR14D15DD15Y16YY16V17VV17R18RR18Y19YY19R20RR20L21LL21P22PP22L23LL23R24RR24V25VV25V26VV26K27KK27H28HH28F29FF29Y30YY30W31WW31T32TT32S33SS33D34DD34S35SS35C36CC36P37PP37R38RR38P39PP39G40GG40V41VV41V42VV42L43LL43L44LL44T45TT45F46FF46R47RR47... and 22 more residue(s)...... and 22 more residue(s)

SMILES None
InChIKey None
Sequence GPYGANMEDSVCCRDYVRYRLPLRVVKHFYWTSDSCPRPGVVLLTFRDKEICADPRVPWVKMILNKLSQ

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

CCL22

G1GG1P2PP2Y3YY3G4GG4A5AA5N6NN6M7MM7E8EE8D9DD9S10SS10V11VV11C12CC12C13CC13R14RR14D15DD15Y16YY16V17VV17R18RR18Y19YY19R20RR20L21LL21P22PP22L23LL23R24RR24V25VV25V26VV26K27KK27H28HH28F29FF29Y30YY30W31WW31T32TT32S33SS33D34DD34S35SS35C36CC36P37PP37R38RR38P39PP39G40GG40V41VV41V42VV42L43LL43L44LL44T45TT45F46FF46R47RR47... and 22 more residue(s)...... and 22 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.